Biotechnology and Innovation Systems
Show Less

Biotechnology and Innovation Systems

The Role of Public Policy

Edited by Bo Göransson and Carl Magnus Pålsson

This book explores how policies targeting public research institutions, such as universities, contribute to the appropriation of biotechnology through national innovation systems.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 6: Biotechnology in Mozambique: Present Situation and Future Trends

Luis Neves, Paula Macucule, Carlos Miguel Ribeiro and Ana Maria da Graça Mondjana


Luis Neves, Paula Macucule, Carlos Miguel Ribeiro and Ana Maria da Graça Mondjana INTRODUCTION Modern biotechnology, which is based on cell biology, molecular biology and genetic engineering, is considered one of the most dynamic branches of the biological sciences and has been the basis for an unprecedented technological and industrial expansion. This fact is testified by the exponential increase in the investment in biotechnology, which is proportional to the increase in the number of patents and technological processes presently in use in agriculture, animal production, aquaculture, medicine and engineering. Biotechnology is generally perceived as a multi-disciplinary complex technological platform that is playing a decisive role in triggering development, notably in presenting a range of solutions to the increase of quantity and quality of food products, in the generation of modern diagnostic tools, therapeutic drugs, and vaccines for combating diseases in humans, animals and plants as well as in presenting alternative processes for industry and environmental management. Although the intellectual and applicative epicentre of this technology was and still is in many aspects located in developed countries, there are many examples of developing countries that have very quickly capitalized on the potential of biotechnology and are important players in devising products, processes, services and other applications which make biotechnology an important vector in their own socio-economic development. However, the vast majority of developing countries could be considered biotechnology marginalized countries, just because they do not meet the criteria either of technology producer or of technology consumer. In spite of all...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information

or login to access all content.